The expression of miR-17-3p and miR-19a-3p in CD34+ cells was significantly higher in the low-grade and high-grade MDS group compared to the normal controls (all P < 0.05) (Fig. 3A,B). The gene discussed is CD34; the disease is myelodysplastic syndrome.